About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3513849
Allelic
Composition
Apctm1Cip/Apc+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Apctm1Cip mutation (0 available); any Apc mutation (158 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• heterozygotes begin to die at 4 months of age with 50% dying by 6 months of age

neoplasm
• in situ carcinomas are seen in both the small and large intestines
• over 50% of lesions in mutants over 12 months of age are tubular adenomas harboring invasive carcinomas
• small and large adenomas are seen throughout the intestine
• the number of polyps is increased and the distribution of polyps shifted towards the ileum under specific pathogen-free conditions
• compared to ApcMin heterozygotes more lesions are see in the colon, however the overall number of lesions is the same in both lines
• 9% of heterozygotes developed mammary adenocanthomas

cardiovascular system
• first seen around 4 months of age, associated with decreased life span

digestive/alimentary system
• first seen around 4 months of age, associated with decreased life span
• rectal prolapse, associated with more severe polyposis in the colon, is seen as early as 4 months of age and is seen in 61% of surviving mutants by 6 months of age
• the prolapse is highly dysplatic and in 10% of these dysplatic areas adenocarcinoma is also seen
• fewer mutants raised in specific pathogen-free conditions developed rectal prolapse
• in situ carcinomas are seen in both the small and large intestines
• over 50% of lesions in mutants over 12 months of age are tubular adenomas harboring invasive carcinomas
• small and large adenomas are seen throughout the intestine
• the number of polyps is increased and the distribution of polyps shifted towards the ileum under specific pathogen-free conditions
• compared to ApcMin heterozygotes more lesions are see in the colon, however the overall number of lesions is the same in both lines

hematopoietic system
• first seen around 4 months of age, associated with decreased life span

endocrine/exocrine glands
• 9% of heterozygotes developed mammary adenocanthomas

integument
• 9% of heterozygotes developed mammary adenocanthomas


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory